Brucella Antibody Test: Complete Guide to Diagnosis, Interpretation, and Clinical Use
🧫 Brucella Antibody (Ab) Test
A Complete Guide for Brucellosis Diagnosis
(Bacterial characteristics · Purpose · Method · Reference ranges · Clinical interpretation · Pitfalls)
1. Characteristics of Brucella Species
Brucella spp. are gram-negative, intracellular coccobacilli that infect humans mainly through contact with infected livestock such as cattle, goats, and sheep.
✔ Key Features
- Intracellular survival → immune evasion and potential for chronic infection
- Main species affecting humans:
Brucella melitensis, B. abortus, B. suis, B. canis - Transmission routes
- Consumption of unpasteurized dairy products (raw milk, cheese)
- Direct contact with infected animals, tissues, or aborted fetuses
- Laboratory exposure
- Common symptoms
- Fever, sweats, myalgia
- Arthritis, spondylitis, epididymo-orchitis
- Chronic fatigue and night sweats in longstanding infection
Because Brucella grows slowly and is difficult to culture, serologic antibody testing is essential for diagnosis.
2. Purpose of the Brucella Antibody Test
The Brucella Ab test is ordered for:
✔ Diagnosis of suspected brucellosis
- Persistent fever, arthralgia, night sweats
- History of livestock exposure
- When blood culture or biopsy results are negative despite strong clinical suspicion
✔ Differentiating acute vs. chronic infection
- IgM elevation: acute phase
- IgG persistence: chronic or past infection
✔ Monitoring treatment response or relapse
- Falling titers → good treatment response
- Rising titers → possible relapse
3. Test Methods
The primary method is the agglutination test, especially the Standard Agglutination Test (SAT).
✔ 1) Standard Agglutination Test (SAT)
- Patient serum is serially diluted and reacted with Brucella antigen
- Visible agglutination indicates antibody presence
- Worldwide traditional diagnostic standard
✔ 2) Additional supplementary tests
- Coombs anti-Brucella test: detects “blocking antibodies” in chronic infection
- ELISA IgM/IgG: higher sensitivity; useful for distinguishing acute vs. chronic
- PCR: supportive in early disease or culture-negative cases
4. Reference Ranges
| Test | Negative | Positive |
|---|---|---|
| SAT | < 1:80 | ≥ 1:160 → suggests active infection |
| ELISA IgM/IgG | Kit-dependent cutoff | Elevated levels suggest infection |
Values vary by region, laboratory, and assay. Always confirm with your local reference standards.
5. Clinical Significance
✔ 1) IgM and IgG Patterns
- IgM ↑ → early/acute infection
- IgG ↑ → ongoing, chronic, or past infection
- High titers (≥1:160) → likely active brucellosis
✔ 2) Antibody titers and their meaning
- Fourfold rise (e.g., 1:80 → 1:320) strongly supports diagnosis
- Decreasing titers → effective treatment
- Re-rising titers → suggest relapse
6. Important Pitfalls in Interpretation
⚠ 1) Cross-reactivity
Antibodies may react with:
- Yersinia
- Francisella
- Salmonella
→ Possible false positives
⚠ 2) Blocking antibodies (prozone effect)
In chronic infection, non-agglutinating antibodies may inhibit visible agglutination → false negatives.
Coombs test is useful here.
⚠ 3) IgG may remain elevated for months to years
Persistent IgG alone does not confirm active infection.
⚠ 4) Pre-analytical errors
Hemolysis, lipemia, or improper storage can affect results.
⚠ 5) Always interpret with clinical findings
Serology alone is insufficient. Combine with culture, PCR, and symptoms.
7. Related Clinical Situations
| Condition | Clinical Relevance |
|---|---|
| Brucellosis | Primary indication |
| Fever of unknown origin (FUO) | Consider in animal-exposed individuals |
| Arthritis, spondylitis | Often seen in chronic brucellosis |
| Epididymo-orchitis | Common in male patients |
| Hepatosplenomegaly | Seen in systemic infection |
8. Key Takeaways
✔ Brucella is intracellular → difficult to diagnose
✔ SAT is the traditional diagnostic standard
✔ Titers ≥1:160 strongly suggest infection
✔ IgG can remain positive long after treatment
✔ Interpretation must combine clinical symptoms + culture + PCR + serology
📚 References
- Corbel MJ. Brucellosis in humans and animals. WHO, 2006.
- Mantur BG et al. Brucellosis: Laboratory aspects. J Lab Physicians.
- Young EJ. Brucella species. In: Mandell, Douglas & Bennett’s Infectious Diseases.
- CDC. Brucellosis Reference Guide.
- Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents.